Kyleen Davis
Primary Care · Chevy Chase, MDNPI 1053644062
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.9% of the total across 272 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,109, 2.6 times the $822 reported in 2021. Among primary care clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 272 payments — averaging $23.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Galderma Laboratories, L.p.$683
- Sanofi$460
- Pfizer$425
- Arcutis Biotherapeutics, Inc.$420
- E.r. Squibb & Sons, L.L.C.$319
- plus $3K from 28 others
What the payments were for
- Food & beverage$6,07394%
- Education$3956%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 38 | $1,088 |
| Galderma Laboratories, L.p. | 25 | $683 |
| Sanofi | 16 | $460 |
| Pfizer | 21 | $425 |
| Arcutis Biotherapeutics, Inc. | 10 | $420 |
| E.r. Squibb & Sons, L.L.C. | 18 | $319 |
| Sun Pharmaceutical Industries Inc. | 17 | $310 |
| Incyte Corporation | 14 | $306 |
| Lilly USA, LLC | 14 | $260 |
| Amgen | 10 | $260 |
| AbbVie | 18 | $255 |
| Boehringer Ingelheim | 10 | $250 |
| Regeneron Healthcare Solutions, Inc. | 7 | $240 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $126 |
| Almirall LLC | 6 | $119 |
| EPI Health, LLC | 5 | $116 |
| Novartis | 5 | $110 |
| Dermavant Sciences, Inc. | 5 | $101 |
| Convatec Inc. | 3 | $77 |
| Revance Therapeutics, Inc. | 1 | $75 |
| LEO Pharma Inc. | 3 | $73 |
| Organogenesis Inc. | 2 | $46 |
| UCB, Inc. | 2 | $44 |
| VYNE Pharmaceuticals Inc. | 3 | $44 |
| Biofrontera Inc. | 2 | $42 |
| Genentech USA, Inc. | 2 | $41 |
| Kerecis Limited | 2 | $28 |
| Botanix SB Inc | 1 | $26 |
| Organon | 1 | $25 |
| Mission Pharmacal Company | 1 | $23 |
| Biowound Solutions, Inc. | 1 | $21 |
| Krystal Biotech Inc | 1 | $20 |
| Dermira, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,468 in reported general payments places this provider in the 95th percentile of 191 primary care providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 61 | $3,793 |
| Fluocinonide | 64 | $2,418 |
| Tacrolimus | 14 | $1,839 |
| Ketoconazole | 117 | $1,770 |
| Metronidazole | 27 | $1,454 |
| Econazole Nitrate | 24 | $1,033 |
| Clindamycin Phosphate | 20 | $899 |
| Triamcinolone Acetonide | 70 | $679 |
| Ciclopirox | 13 | $443 |
| Doxycycline Monohydrate | 20 | $414 |
| Minoxidil | 39 | $293 |
| Mupirocin | 12 | $142 |
| ValacyclovirValacyclovir Hcl | 13 | $119 |
Paid to pharmacies, not to this prescriber.
Other primary care in Chevy Chase
- Ashley SalamoneBaltimore$13K
- Ololade IkuomolaBaltimore$10K
- Patricia GoodmanUppr Marlboro$8K
- Jody LeonardAnnapolis$7K
- Yury MalachevskyBaltimore$7K
- Laura Ferguson-WeigmanBel Air$5K
- Roza LissGaithersburg$5K
- Anita Tuli-KendallGaithersburg$5K
- Hannah WhiteheadEssex$4K
- Ryan BarnesMillersville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.